Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Oakland › NPI 1003961251
Hospital

Children's Hospital & Research Center at Oakland

Children's Hospital & Research Center at Oakland was paid $161.81M by Medicaid between Jan 2018 and Dec 2024, across 610 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 31% of everything it billed.

33Billing provider infoCHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND
OAKLAND, CA 94609
33aNPI1003961251assigned 01/25/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$161.81M
24GClaims2,536,928
24DCodes billed610
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#8 of 410
Median peer was paid$6.90M
This provider vs. median23×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018310,718$23.47M
2019325,621$20.50M
2020287,833$17.68M
2021392,519$23.41M
2022395,142$20.47M
2023422,373$27.35M
2024incomplete402,722$28.94M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 31% 176,215 157,848 $50.23M
99231 Subsequent hospital care, per day, straightforward or low complexity 5.6% 212,121 174,962 $9.03M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.7% 97,078 88,848 $7.55M
90378 2.7% 1,372 1,133 $4.36M
0510 2.0% 68,841 62,415 $3.20M
0450 Emergency room services 1.7% 38,417 36,013 $2.80M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1.7% 1,392 1,007 $2.76M
Q3014 Telehealth originating site facility fee 1.5% 64,900 62,183 $2.43M
Z5946 1.5% 890 886 $2.42M
99199 Unlisted special service, procedure or report 1.4% 39,817 32,166 $2.28M
70551 Magnetic resonance imaging, brain; without contrast material 1.4% 3,531 3,358 $2.19M
Z7500 1.3% 176,836 166,050 $2.09M
598 more codes
0202U Oncology (prostate), multianalyte, gene expression profiling 1.2% 5,825 $1.87M
P9016 Red blood cells, leukocytes reduced, each unit 1.1% 2,990 $1.81M
0123 1.1% 208 $1.74M
93325 1.0% 8,907 $1.63M
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 2,330 $1.52M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,554 $1.48M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 20,025 $1.42M
36455 <1% 3,244 $1.41M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 14,348 $1.35M
92557 <1% 17,778 $1.30M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 3,450 $1.18M
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,058 $1.14M
29705 <1% 6,999 $1.11M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 15,074 $1.02M
X4500 <1% 8,719 $822K
97139 <1% 81,261 $818K
99213 Doctor's office visit, returning patient (routine) <1% 102,955 $780K
80053 Comprehensive metabolic panel <1% 32,771 $778K
99201 <1% 14,126 $750K
76770 <1% 5,656 $728K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 5,247 $697K
99070 <1% 6,300 $694K
99214 Doctor's office visit, returning patient (more involved) <1% 46,542 $680K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,782 $644K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 583 $625K
93975 <1% 1,649 $615K
99283 Emergency room visit (moderate) <1% 3,379 $613K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,298 $607K
92551 <1% 34,314 $597K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 1,126 $585K
0360 <1% 480 $575K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 13,701 $566K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,967 $548K
J3490 Unclassified drugs <1% 19,692 $535K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) <1% 4,019 $520K
92588 <1% 8,433 $491K
95782 <1% 255 $478K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 672 $470K
92567 <1% 17,736 $463K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,801 $455K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 10,151 $453K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,347 $444K
41899 Unlisted procedure, dentoalveolar structures <1% 220 $423K
70450 Computed tomography, head or brain; without contrast material <1% 1,125 $417K
76825 <1% 2,188 $415K
87631 <1% 4,018 $412K
73100 <1% 5,081 $402K
69210 <1% 1,970 $391K
90834 Psychotherapy session, about 45 minutes <1% 2,700 $390K
76827 <1% 2,205 $382K
86923 <1% 2,164 $382K
31575 <1% 993 $382K
84443 Thyroid stimulating hormone (TSH) <1% 11,220 $369K
93304 <1% 3,137 $365K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,052 $361K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,046 $360K
97802 <1% 2,653 $336K
96910 <1% 5,076 $335K
73610 <1% 6,065 $330K
83036 Hemoglobin; glycosylated (A1C) <1% 20,543 $329K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 869 $328K
71046 Radiologic examination, chest; 2 views <1% 8,133 $327K
73090 <1% 5,191 $324K
0521 <1% 6,046 $324K
29799 <1% 5,055 $311K
93976 <1% 1,146 $293K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,381 $293K
29075 <1% 2,377 $292K
86003 <1% 27,503 $291K
97750 <1% 14,310 $291K
73080 <1% 4,759 $289K
X4540 <1% 8,531 $280K
29065 <1% 1,567 $278K
93321 <1% 5,143 $278K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,393 $272K
72082 <1% 2,968 $260K
86920 <1% 807 $256K
86480 <1% 2,392 $252K
73110 <1% 4,099 $250K
Z7502 <1% 6,726 $250K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 13,975 $243K
86922 <1% 690 $240K
73630 <1% 5,130 $235K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,905 $225K
T1024 Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter <1% 4,574 $220K
76870 <1% 2,288 $218K
95819 <1% 3,377 $217K
86902 <1% 4,041 $214K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,919 $214K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 10,319 $212K
0001A <1% 3,893 $206K
0700 <1% 3,653 $205K
96375 Therapeutic injection; each additional sequential IV push <1% 3,412 $203K
73070 <1% 2,725 $200K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 12,581 $200K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,384 $197K
74018 <1% 5,624 $192K
0002A <1% 3,610 $192K
76536 <1% 1,884 $190K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,174 $190K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,929 $190K
73140 <1% 4,320 $187K
73590 <1% 3,722 $186K
97799 <1% 10,211 $185K
T1999 Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" <1% 5,593 $184K
93308 <1% 1,421 $184K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,483 $183K
82728 <1% 8,097 $182K
72170 <1% 4,375 $175K
76981 <1% 1,162 $174K
97803 <1% 1,599 $174K
84439 <1% 9,795 $173K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 744 $173K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,517 $170K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,779 $167K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 20,190 $164K
96361 Intravenous infusion, hydration; each additional hour <1% 2,686 $154K
92582 <1% 3,956 $152K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 3,644 $151K
73130 <1% 2,784 $150K
92579 <1% 5,588 $146K
87390 <1% 4,768 $144K
94664 <1% 5,662 $144K
99417 Prolong home eval add 15m <1% 1,961 $143K
87088 <1% 10,026 $136K
87486 <1% 2,553 $135K
87581 <1% 2,554 $135K
86141 <1% 6,487 $134K
0272 <1% 1,206 $129K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 272 $126K
86364 <1% 2,876 $125K
99215 Doctor's office visit, returning patient (complex) <1% 3,219 $123K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 5,898 $121K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 48,649 $117K
X4303 <1% 1,773 $115K
95816 <1% 1,280 $113K
81001 <1% 16,113 $111K
G9920 Screening performed and negative <1% 6,312 $110K
87077 <1% 4,826 $110K
73562 <1% 2,270 $107K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,363 $106K
29405 <1% 406 $103K
73564 <1% 2,290 $103K
86235 <1% 384 $102K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 2,546 $102K
83718 <1% 6,826 $101K
83516 <1% 6,046 $101K
84703 <1% 9,878 $101K
0071A <1% 1,861 $99K
86702 <1% 4,784 $98K
76885 <1% 825 $98K
Z4300 <1% 950 $98K
Z5822 <1% 3,541 $97K
G9002 Coordinated care fee, maintenance rate <1% 483 $95K
0072A <1% 1,803 $95K
81003 <1% 11,243 $92K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,300 $92K
97161 <1% 2,517 $92K
92700 <1% 1,680 $90K
93320 <1% 849 $89K
94799 <1% 649 $88K
T1001 Nursing assessment / evaluation <1% 1,610 $86K
84466 <1% 3,422 $85K
72081 <1% 1,782 $84K
98967 <1% 2,425 $83K
83020 <1% 3,918 $82K
93226 <1% 670 $81K
84403 <1% 1,927 $81K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 994 $81K
76820 <1% 1,755 $80K
90837 Psychotherapy session, about an hour <1% 664 $80K
76813 <1% 570 $76K
83690 <1% 4,695 $76K
0780 <1% 1,527 $75K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 864 $75K
0761 <1% 1,668 $75K
85018 <1% 23,590 $75K
99204 Doctor's office visit, new patient (more involved) <1% 673 $74K
0760 <1% 1,864 $74K
Z7610 <1% 5,817 $74K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,881 $73K
82784 <1% 5,678 $72K
74019 <1% 1,551 $72K
94010 <1% 2,487 $71K
86701 <1% 4,786 $69K
90686 <1% 13,114 $68K
83721 <1% 4,129 $67K
82803 <1% 1,136 $67K
87081 <1% 4,994 $67K
Z5406 <1% 3,892 $67K
82330 <1% 1,843 $66K
86481 <1% 502 $66K
Z4301 <1% 2,354 $65K
99368 <1% 3,060 $65K
Z5932 <1% 1,349 $65K
Z5958 <1% 405 $65K
X4542 <1% 1,061 $65K
P9022 Red blood cells, washed, each unit <1% 84 $63K
73221 <1% 89 $63K
73552 <1% 1,278 $63K
29125 <1% 682 $62K
77073 <1% 1,548 $61K
54161 <1% 49 $61K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,471 $61K
84305 <1% 1,909 $60K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,474 $59K
93225 <1% 729 $59K
J3380 Injection, vedolizumab, intravenous, 1 mg <1% 50 $58K
73000 <1% 1,514 $58K
72141 <1% 89 $57K
77072 <1% 2,238 $56K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 212 $54K
82465 <1% 7,004 $54K
71045 Radiologic examination, chest; single view <1% 1,805 $53K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 37 $51K
Z4308 <1% 1,878 $50K
86850 <1% 5,463 $50K
91320 <1% 358 $49K
83993 <1% 1,520 $49K
96127 <1% 9,125 $49K
92060 <1% 2,882 $49K
82670 <1% 1,108 $49K
90682 <1% 1,620 $49K
73030 <1% 996 $48K
S0265 Genetic counseling, under physician supervision, each 15 minutes <1% 764 $48K
84478 <1% 4,396 $47K
82785 <1% 1,378 $47K
83540 <1% 3,515 $46K
82948 <1% 7,610 $46K
87040 <1% 1,761 $46K
92595 <1% 503 $46K
X4110 <1% 1,471 $45K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,063 $44K
11900 <1% 312 $44K
92522 <1% 364 $44K
99000 <1% 5,423 $44K
83550 <1% 3,133 $44K
85045 <1% 6,011 $43K
80051 <1% 1,244 $43K
73560 <1% 977 $42K
84100 <1% 5,169 $42K
93786 <1% 641 $42K
84460 <1% 4,349 $41K
70486 <1% 103 $40K
17110 <1% 1,283 $39K
94644 <1% 1,076 $39K
80048 Basic metabolic panel (calcium, ionized) <1% 2,162 $39K
91319 <1% 397 $38K
Z4303 <1% 881 $38K
Z4307 <1% 1,303 $38K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 4,495 $37K
90381 <1% 40 $37K
87799 <1% 652 $37K
V5264 Ear mold/insert, not disposable, any type <1% 667 $37K
72100 <1% 628 $37K
87070 <1% 2,269 $36K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 2,914 $36K
86803 <1% 1,256 $36K
99188 <1% 973 $35K
82397 <1% 1,758 $34K
73060 <1% 740 $34K
84450 <1% 3,678 $33K
84402 <1% 802 $33K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,600 $33K
97010 <1% 766 $33K
0710 <1% 438 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 6,719 $33K
31231 <1% 163 $33K
83605 <1% 1,220 $33K
86258 <1% 1,179 $33K
83735 <1% 2,302 $33K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,368 $33K
86140 <1% 3,465 $32K
Z4304 <1% 416 $32K
Z4311 <1% 2,561 $32K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,573 $32K
86901 <1% 5,728 $31K
87184 <1% 3,080 $31K
83001 <1% 1,216 $31K
85027 <1% 2,334 $30K
83002 <1% 1,033 $30K
98960 <1% 417 $30K
S9470 Nutritional counseling, dietitian visit <1% 598 $30K
86900 <1% 5,727 $30K
83655 <1% 5,862 $29K
92504 <1% 913 $29K
82565 <1% 3,252 $29K
86008 <1% 900 $28K
82977 <1% 2,002 $28K
85660 <1% 1,927 $27K
0636 <1% 181 $27K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 155 $27K
90461 <1% 18,415 $27K
94060 <1% 484 $27K
73660 <1% 703 $27K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 29 $27K
30901 <1% 117 $26K
72146 <1% 37 $26K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,240 $26K
85246 <1% 522 $26K
85651 <1% 4,177 $26K
92081 <1% 442 $25K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 4,205 $25K
86592 <1% 3,127 $25K
90691 <1% 216 $25K
25605 <1% 81 $25K
X4532 <1% 728 $24K
84145 <1% 546 $24K
0054A <1% 444 $24K
87340 <1% 1,148 $24K
85652 <1% 4,662 $24K
85245 <1% 484 $23K
76882 <1% 1,068 $23K
97804 <1% 481 $23K
X4530 <1% 470 $22K
36600 <1% 739 $22K
99366 <1% 1,029 $22K
82570 <1% 2,297 $22K
86256 <1% 1,118 $21K
85610 <1% 2,494 $21K
0270 <1% 27 $21K
86706 <1% 937 $21K
Z4312 <1% 1,704 $21K
85730 <1% 1,565 $20K
86038 <1% 875 $20K
82947 <1% 2,513 $20K
82610 <1% 998 $19K
12011 <1% 482 $19K
83615 <1% 1,532 $19K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 193 $19K
85240 <1% 497 $19K
76826 <1% 95 $18K
74240 <1% 141 $18K
X3908 <1% 583 $18K
99232 Hospital visit by a doctor, follow-up day <1% 105 $18K
84520 <1% 2,527 $17K
X4304 <1% 535 $17K
85384 <1% 791 $17K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 995 $17K
72190 <1% 514 $17K
92511 <1% 116 $16K
82627 <1% 348 $16K
36512 <1% 12 $16K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 452 $16K
83498 <1% 758 $15K
0052A <1% 277 $15K
X4522 <1% 46 $15K
V5267 Hearing aid or assistive listening device/supplies/accessories, not otherwise specified <1% 192 $15K
87205 <1% 1,754 $15K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,972 $14K
J7050 Infusion, normal saline solution, 250 cc <1% 1,325 $14K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 928 $14K
87497 <1% 224 $14K
94770 <1% 531 $14K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,256 $13K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 204 $13K
80061 Lipid panel <1% 448 $13K
29105 <1% 119 $13K
J2704 Injection, propofol, 10 mg <1% 3,134 $12K
X4112 <1% 1,160 $12K
92585 <1% 80 $12K
76506 <1% 145 $11K
92650 <1% 38 $11K
99156 <1% 80 $11K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 696 $11K
0004A <1% 201 $11K
83525 <1% 501 $11K
83030 <1% 777 $11K
70360 <1% 309 $10K
76828 <1% 95 $10K
72020 <1% 151 $10K
84550 <1% 963 $10K
92594 <1% 202 $9K
12001 <1% 176 $9K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 37 $9K
86376 <1% 540 $9K
97165 <1% 195 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,128 $9K
0051A <1% 169 $9K
90832 Psychotherapy session, about 30 minutes <1% 181 $9K
90656 <1% 1,482 $9K
84480 <1% 281 $8K
Z4310 <1% 503 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,597 $8K
84156 <1% 1,169 $8K
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 633 $8K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 248 $8K
69200 <1% 27 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,034 $7K
80076 <1% 467 $7K
86682 <1% 330 $7K
93788 <1% 640 $7K
91318 <1% 100 $7K
0124A <1% 116 $7K
99080 <1% 79 $7K
51798 <1% 28 $7K
96409 <1% 242 $7K
J9370 Vincristine sulfate, 1 mg <1% 544 $7K
99205 Prolong outpt/office vis <1% 62 $7K
87427 <1% 350 $7K
82550 <1% 423 $6K
Z4309 <1% 136 $6K
87177 <1% 346 $6K
82043 <1% 600 $6K
X3910 <1% 509 $6K
0154A <1% 112 $6K
84146 <1% 180 $6K
11750 <1% 48 $6K
87045 <1% 333 $6K
J2270 Injection, morphine sulfate, up to 10 mg <1% 654 $6K
90688 <1% 238 $6K
0074A <1% 88 $6K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 14 $6K
29345 <1% 12 $5K
99244 Office or other outpatient consultation, moderate to high complexity <1% 257 $5K
87634 <1% 62 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,005 $5K
87046 <1% 975 $5K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 832 $5K
85007 <1% 711 $5K
83970 <1% 55 $5K
V5140 Binaural, behind the ear <1% 123 $5K
95812 <1% 74 $5K
70544 <1% 12 $5K
96415 <1% 94 $5K
99218 <1% 78 $5K
87147 <1% 590 $5K
86160 <1% 202 $5K
G9919 Screening performed and positive and provision of recommendations <1% 167 $4K
82103 <1% 418 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $4K
H2015 Community support for mental illness or disability, per 15 minutes <1% 90 $4K
92610 <1% 90 $4K
73600 <1% 40 $4K
92604 <1% 54 $4K
87015 <1% 326 $4K
54640 <1% 15 $4K
95700 <1% 12 $4K
Z5936 <1% 45 $4K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 55 $4K
73620 <1% 27 $4K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 3,445 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 979 $4K
82247 <1% 463 $4K
74230 <1% 53 $4K
76642 <1% 30 $3K
J8540 Dexamethasone, oral, 0.25 mg <1% 862 $3K
X4100 <1% 67 $3K
85576 <1% 77 $3K
94645 <1% 89 $3K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 192 $3K
82104 <1% 318 $3K
86708 <1% 144 $3K
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg <1% 103 $3K
Z7504 <1% 59 $3K
82657 <1% 89 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 131 $3K
82390 <1% 430 $3K
29515 <1% 47 $3K
X4301 <1% 29 $3K
90791 Psychiatric diagnostic evaluation <1% 48 $3K
92603 <1% 25 $3K
82248 <1% 278 $3K
83986 <1% 261 $3K
86704 <1% 84 $3K
X4300 <1% 26 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 114 $2K
99157 <1% 15 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 419 $2K
96112 <1% 15 $2K
94760 <1% 166 $2K
71020 <1% 67 $2K
84202 <1% 72 $2K
87101 <1% 175 $2K
80299 <1% 112 $2K
X3920 <1% 42 $2K
86225 <1% 76 $2K
87481 <1% 50 $2K
99221 <1% 27 $2K
0112A <1% 30 $2K
Z5928 <1% 43 $2K
0082A <1% 29 $2K
86665 <1% 211 $2K
80069 <1% 98 $2K
86880 <1% 189 $2K
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 328 $2K
93971 <1% 15 $2K
85670 <1% 130 $2K
86800 <1% 66 $2K
72070 <1% 14 $2K
90651 <1% 509 $2K
0081A <1% 26 $2K
G9019 Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) <1% 109 $2K
Z7506 <1% 12 $2K
94726 <1% 24 $1K
82652 <1% 78 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 143 $1K
87807 <1% 79 $1K
84445 <1% 26 $1K
99173 <1% 17,845 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 18 $1K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 137 $1K
72040 <1% 24 $1K
92526 <1% 29 $1K
11730 <1% 13 $1K
92523 <1% 16 $1K
V5020 Conformity evaluation <1% 13 $1K
77080 <1% 25 $1K
74000 <1% 52 $1K
29700 <1% 19 $1K
86308 <1% 98 $1K
81513 <1% 25 $1K
86663 <1% 111 $1K
86664 <1% 111 $1K
J7999 Compounded drug, not otherwise classified <1% 75 $950.17
0250 <1% 284 $942.58
94729 <1% 12 $916.88
V5266 Battery for use in hearing device <1% 13 $914.11
87186 <1% 74 $901.92
92250 <1% 44 $876.29
84630 <1% 152 $874.24
G2063 Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes <1% 21 $855.54
82985 <1% 95 $855.40
92587 <1% 15 $806.77
0111A <1% 12 $804.00
36415 Collection of venous blood by venipuncture <1% 2,799 $796.06
92570 <1% 16 $791.55
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 175 $778.89
87209 <1% 48 $723.36
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 39 $700.00
70250 <1% 12 $695.14
85008 <1% 410 $669.75
Z7512 <1% 25 $653.25
X3922 <1% 25 $651.00
J0780 Injection, prochlorperazine, up to 10 mg <1% 43 $629.08
90685 <1% 17 $626.54
A9150 Non-prescription drugs <1% 1,633 $603.74
86580 <1% 57 $552.91
86705 <1% 26 $538.69
92611 <1% 17 $525.10
87210 <1% 82 $493.55
84484 <1% 26 $481.83
80143 <1% 13 $478.59
82085 <1% 71 $451.30
84590 <1% 26 $432.53
86015 <1% 93 $403.74
87338 <1% 12 $386.14
80179 <1% 12 $374.97
X4102 <1% 13 $357.00
90670 <1% 548 $333.03
99408 <1% 4,472 $314.75
84446 <1% 26 $311.60
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 15 $302.01
90647 <1% 248 $301.00
J3475 Injection, magnesium sulfate, per 500 mg <1% 27 $291.87
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 142 $283.32
99001 <1% 3,177 $256.55
83921 <1% 14 $256.12
82157 <1% 12 $246.96
88304 <1% 12 $245.85
86709 <1% 14 $223.30
84270 <1% 14 $220.22
76000 <1% 13 $200.09
82150 <1% 12 $182.81
90723 <1% 139 $153.01
Z4302 <1% 12 $144.60
90480 <1% 440 $120.00
90633 <1% 401 $101.01
99245 <1% 80 $89.38
0320 <1% 81 $84.94
90734 <1% 350 $72.02
99383 <1% 35 $60.31
85014 <1% 12 $57.31
90680 <1% 45 $45.00
90681 <1% 12 $36.00
0370 <1% 60 $28.50
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 65 $14.32
96160 <1% 578 $7.94
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 53 $3.66
A4217 Sterile water/saline, 500 ml <1% 12 $0.13
90716 <1% 13 $0.01
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 884 $0.00
90715 0% 139 $0.00
90710 0% 100 $0.00
0300 0% 28 $0.00
97810 0% 41 $0.00
90648 0% 14 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 160 $0.00
0258 0% 197 $0.00
3008F 0% 16 $0.00
91315 0% 26 $0.00
0305 0% 108 $0.00
0306 0% 85 $0.00
90696 0% 72 $0.00
0301 0% 99 $0.00
0307 0% 26 $0.00
97166 0% 12 $0.00
0410 0% 27 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOLMES, NICOLAS (PRESIDENT)